Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform
Glioblastoma (GBM) is one of most aggressive forms of brain cancer, with a median survival time of 14.6 months following diagnosis. This low survival rate could in part be attributed to the lack of model systems of this type of cancer that faithfully recapitulate the tumor architecture and microenvi...
Main Authors: | Hemamylammal Sivakumar, Roy Strowd, Aleksander Skardal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Gels |
Subjects: | |
Online Access: | https://www.mdpi.com/2310-2861/3/3/28 |
Similar Items
-
Multi-Cell Type Glioblastoma Tumor Spheroids for Evaluating Sub-Population-Specific Drug Response
by: Hemamylammal Sivakumar, et al.
Published: (2020-09-01) -
Prognosis and Survival Study in Patients with Glioblastoma Multiform and Its Relationship with EGFR Expression
by: Zeinab Amirpour, et al.
Published: (2020-07-01) -
EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence
by: Li Li, et al.
Published: (2018-12-01) -
EGFR alterations in glioblastoma play a role in antitumor immunity regulation
by: Xiao-Peng Li, et al.
Published: (2023-08-01) -
The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in IDH Wild-Type Glioblastoma
by: Brandon Kaye, et al.
Published: (2023-05-01)